The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
QTc Prolongation, Torsades de Pointes, and Psychotropic Medications
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
Surawicz, B., Childers, R., Deal, B. J., & Gettes, L. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.013 · Cited by 2,032
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
Sertraline treatment of major depression in patients with acute MI or unstable angina
Glassman, A. H. (2002) · JAMA · doi:10.1001/jama.288.6.701 · Cited by 1,414
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
Drug induced QT prolongation and torsades de pointes
Yap, Y. G., & Camm, A. J. (2003) · Heart · doi:10.1136/heart.89.11.1363 · Cited by 958
Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death
Glassman, A. H., & Bigger, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1774 · Cited by 822
Lespérance, F., Frasure-Smith, N., Koszycki, D., Laliberté, M.-A., van Zyl, L. T., Baker, B., Swenson, J. R., Ghatavi, K., Abramson, B. L., Dorian, P., et al. (2007) · JAMA · doi:10.1001/jama.297.4.367 · Cited by 658
Goldenberg, I., & Moss, A. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.068 · Cited by 651
QT interval prolongation predicts cardiovascular mortality in an apparently healthy population.
Schouten, E. G., Dekker, J. M., Meppelink, P., Kok, F. J., Vandenbroucke, J. P., & Pool, J. (1991) · Circulation · doi:10.1161/01.cir.84.4.1516 · Cited by 630
Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes
Yang, P., Kanki, H., Drolet, B., Yang, T., Wei, J., Viswanathan, P. C., Hohnloser, S. H., Shimizu, W., Schwartz, P. J., Stanton, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014448.19052.4c · Cited by 554
Measurement of the QT interval and the risk associated with QTc interval prolongation: A review
Moss, A. J. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90036-c · Cited by 472
Comparison of Paroxetine and Nortriptyline in Depressed Patients With Ischemic Heart Disease
Roose, S. P. (1998) · JAMA · doi:10.1001/jama.279.4.287 · Cited by 453
Antipsychotics and the Risk of Sudden Cardiac Death
Ray, W. A., Meredith, S., Thapa, P. B., Meador, K. G., Hall, K., & Murray, K. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1161 · Cited by 429
Rautaharju, P. M., Surawicz, B., & Gettes, L. S. (2009) · Circulation · doi:10.1161/circulationaha.108.191096 · Cited by 408
Roden, D. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0706513 · Cited by 380
Harrigan, E. P., Miceli, J. J., Anziano, R., Watsky, E., Reeves, K. R., Cutler, N. R., Sramek, J., Shiovitz, T., & Middle, M. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000104913.75206.62 · Cited by 363
Accurate electrocardiographic assessment of the QT interval: Teach the tangent
Postema, P. G., De Jong, J. S. S. G., Van der Bilt, I. A. C., & Wilde, A. A. M. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.03.037 · Cited by 317
Wright, P., Birkett, M., David, S. R., Meehan, K., Ferchland, I., Alaka, K. J., Saunders, J. C., Krueger, J., Bradley, P., San, L., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1149 · Cited by 303
Breier, A., Meehan, K., Birkett, M., David, S., Ferchland, I., Sutton, V., Taylor, C. C., Palmer, R., Dossenbach, M., Kiesler, G., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.5.441 · Cited by 289
Evaluation of Drug-Induced QT Interval Prolongation: Implications for Drug Approval and Labelling
Malik, M., & Camm, A. J. (2001) · Drug Safety · doi:10.2165/00002018-200124050-00001 · Cited by 273
Vieweg, W. V. R., Hasnain, M., Howland, R. H., Hettema, J. M., Kogut, C., Wood, M. A., & Pandurangi, A. K. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.12.002 · Cited by 270
Citrome, L. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02228.x · Cited by 266
Hennessy, S., Bilker, W. B., Knauss, J. S., Margolis, D. J., Kimmel, S. E., Reynolds, R. F., Glasser, D. B., Morrison, M. F., & Strom, B. L. (2002) · BMJ · doi:10.1136/bmj.325.7372.1070 · Cited by 261
Antipsychotics and the Risk of Sudden Cardiac Death
Straus, S. M. J. M., Bleumink, G. S., Dieleman, J. P., van der Lei, J., ‘t Jong, G. W., Kingma, J. H., Sturkenboom, M. C. J. M., & Stricker, B. H. C. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.12.1293 · Cited by 260
Stiefel, G., & Besag, F. M. C. (2010) · Drug Safety · doi:10.2165/11536380-000000000-00000 · Cited by 257
QTc Prolongation by Psychotropic Drugs and the Risk of Torsade de Pointes
Wenzel-Seifert, K., Wittmann, M., & Haen, E. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0687 · Cited by 256
Strik, J. J. M. H., Honig, A., Lousberg, R., Lousberg, A. H. P., Cheriex, E. C., Tuynman-Qua, H. G., J. C. Kuijpers, P. M., Wellens, H. J. J., & Van Praag, H. M. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200011000-00007 · Cited by 254
Cardiovascular Effects of Fluoxetine in Depressed Patients With Heart Disease
Roose, S. P., Glassman, A. H., Attia, E., Woodring, S., Giardina, E.-G. V., & Bigger, J. T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.5.660 · Cited by 212
Mehtonen, O. ‐., Aranko, K., Mälkonen, L., & Vapaatalo, H. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb01421.x · Cited by 187
(1963) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1963.03710030141099 · Cited by 187
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients
Curtis, L. H., Østbye, T., Sendersky, V., Hutchison, S., Allen LaPointe, N. M., Al-Khatib, S. M., Usdin Yasuda, S., Dans, P. E., Wright, A., Califf, R. M., et al. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01455-9 · Cited by 176
QT Alterations in Psychopharmacology: Proven Candidates and Suspects
Alvarez, P., & Pahissa, J. (2010) · Current Drug Safety · doi:10.2174/157488610789869265 · Cited by 173
Antipsychotic drugs and QT prolongation
Stöllberger, C., Huber, J. O., & Finsterer, J. (2005) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000166405.49473.70 · Cited by 168
Hoffmann, P., & Warner, B. (2006) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.07.003 · Cited by 167
Cardiovascular Effects of Tricyclic and Tetracyclic Antidepressants
BURCKHARDT, D., Raeder, E., Müller, V., Imhof, P., & Neubauer, H. (1978) · JAMA · doi:10.1001/jama.1978.03280300045019 · Cited by 154
Tricyclic Antidepressants, QT Interval Prolongation, and Torsade de Pointes
Vieweg, W. V. R., & Wood, M. A. (2004) · Psychosomatics · doi:10.1176/appi.psy.45.5.371 · Cited by 150
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients
Curtis, L. H., Østbye, T., & Sendersky, V. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00200-9 · Cited by 149
Long QT syndrome caused by noncardiac drugs
Viskin, S., Justo, D., Halkin, A., & Zeltser, D. (2003) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2003.00101 · Cited by 142
Poluzzi, E., Raschi, E., Moretti, U., & Ponti, F. D. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1746 · Cited by 138
QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia
Ozeki, Y., Fujii, K., Kurimoto, N., Yamada, N., Okawa, M., Aoki, T., Takahashi, J. A., Ishida, N., Horie, M., & Kunugi, H. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.01.008 · Cited by 128
Comparative Toxicity of Citalopram and the Newer Antidepressants After Overdose
Kelly, C. A., Dhaun, N., Laing, W. J., Strachan, F. E., Good, A. M., & Bateman, D. N. (2004) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120028747 · Cited by 127
Awudu, G. A. H., & Besag, F. (2014) · Drug Safety · doi:10.1007/s40264-014-0201-8 · Cited by 125
Witchel, H. J., Pabbathi, V. K., Hofmann, G., Paul, A. A., & Hancox, J. C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03320-8 · Cited by 117
Antidepressant Use and Risk of Out-of-Hospital Cardiac Arrest: A Nationwide Case–Time–Control Study
Weeke, P. E., Jensen, A. K. G., Folke, F., Gislason, G., Olesen, J. B., Andersson, C., Fosbøl, E. L., Larsen, J. K., Lippert, F. K., Nielsen, S. L., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.368 · Cited by 111
Safety Profile of Iloperidone: A Pooled Analysis of 6-Week Acute-Phase Pivotal Trials
Weiden, P. J., Cutler, A. J., Polymeropoulos, M. H., & Wolfgang, C. D. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181694f5a · Cited by 104
Cardiac Safety of Citalopram: Prospective Trials and Retrospective Analyses
Rasmussen, S. L., Overø, K. F., & Tanghøj, P. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910000-00004 · Cited by 103
Jiang, W., O’Connor, C. M., Silva, S. G., Kuchibhatla, M. N., Cuffe, M. S., Callwood, D. D., Zakhary, B., Henke, E., Arias, R. M., & Krishnan, R. R. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.05.003 · Cited by 102
Association of antipsychotic and antidepressant drugs with Q-T interval prolongation
Zemrak, W. R., & Kenna, G. A. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070279 · Cited by 102
Pharmacokinetic–pharmacodynamic modelling of QT interval prolongation following citalopram overdoses
Friberg, L. E., Isbister, G. K., & Duffull, S. B. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02546.x · Cited by 91
Cheng, M., Gao, H., Xu, L., Li, B., Zhang, H., & Li, X. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181379ef6 · Cited by 90
QTc Interval Prolongation Associated with Citalopram Overdose: A Case Report and Literature Review
Catalano, G., Catalano, M. C., Epstein, M. A., & Tsambiras, P. E. (2001) · Clinical Neuropharmacology · doi:10.1097/00002826-200105000-00007 · Cited by 83
Gbadebo, T. D., Trimble, R. W., Khoo, M. S. C., Temple, J., Roden, D. M., & Anderson, M. E. (2002) · Circulation · doi:10.1161/hc0602.103724 · Cited by 81
Citalopram overdose: Late presentation of torsades de pointes (TdP) with cardiac arrest
Tarabar, A. F., Hoffman, R. S., & Nelson, L. S. (2008) · Journal of Medical Toxicology · doi:10.1007/bf03160963 · Cited by 72
Sudden death in patients receiving drugs tending to prolong the QT interval
Jolly, K. B., GAMMAGE, M. D., Cheng, K. K., Bradburn, P., Banting, M., & Langman, M. J. S. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03496.x · Cited by 67
Torsades de Pointes Associated With Ziprasidone
Heinrich, T. W., Biblo, L. A., & Schneider, J. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.3.264 · Cited by 62
Comparative effects of fluoxetine and amitriptyline on cardiac function.
Upward, J., Edwards, J. G., Goldie, A., & Waller, D. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03397.x · Cited by 61
Bupropion Overdose: QTc Prolongation and its Clinical Significance
Isbister, G. K., & Balit, C. R. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c481 · Cited by 60
Activated Charcoal Decreases the Risk of QT Prolongation After Citalopram Overdose
Isbister, G. K., Friberg, L. E., Stokes, B., Buckley, N. A., Lee, C. S., Gunja, N., Brown, S. G. A., MacDonald, E., Graudins, A., Holdgate, A., et al. (2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.03.009 · Cited by 58
Potkin, S. G., Ogasa, M., Cucchiaro, J. B., & Loebel, A. D. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.04.008 · Cited by 58
Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder
Yeragani, V. K., Pohl, R., Jampala, V. C., Balon, R., Ramesh, C., & Srinivasan, K. (2000) · Depression and Anxiety · Cited by 57
QT interval prolongation associated with venlafaxine administration
Letsas, Κ. P., Korantzopoulos, P. G., Pappas, L. K., Evangelou, D., Efremidis, M., & Kardaras, F. G. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.03.065 · Cited by 57
Electrocardiographic Effects of Fluoxetine and Doxepin in Patients With Major Depressive Disorder
Baker, B., Dorian, P., Sandor, P., Shapiro, C. M., Schell, C., Mitchell, J., & Irvine, M. J. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199702000-00004 · Cited by 53
Investigation of the Potential of Clozapine to Cause Torsade de Pointes
Warner, B., & Hoffmann, P. (2002) · Adverse Drug Reactions and Toxicological Reviews · doi:10.1007/bf03256196 · Cited by 53
Citalopram induced torsade de pointes, a rare life threatening side effect
Kanjanauthai, S., Kanluen, T., & Chareonthaitawee, P. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.08.006 · Cited by 51
Prolonged QTc intervals in medicated patients with schizophrenia
Chong, S. A., Mythily, Lum, A., Goh, H. Y., & Chan, Y. H. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.540 · Cited by 49
Aripiprazole versus placebo for schizophrenia
Belgamwar, R. B., & El-Sayeh, H. G. G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006622.pub2 · Cited by 48
Vieweg, W. V. R., Schneider, R. K., & Wood, M. A. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00592.x · Cited by 47
Citalopram in the Treatment of Depression and Other Potential Uses in Psychiatry
Tan, J. Y., & Levin, G. M. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.9.675.31538 · Cited by 46
The Safety and Tolerability of Duloxetine Compared With Paroxetine and Placebo
Nelson, J. C., Pritchett, Y., Martynov, O., Yu, J., Mallinckrodt, C. H., & Detke, M. J. (2006) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v08n0404 · Cited by 44
Effect of fluoxetine, pemoline and placebo on heart period and QT variability in normal humans
Pohl, R. B., Balon, R., Jayaraman, A., Doll, R. G., & Yeragani, V. K. (2003) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00478-6 · Cited by 43
Prolonged QTc interval and torsades de pointes induced by citalopram.
Deshmukh, A. R., Ulveling, K. G., Alla, V. M., Abuissa, H. S., & Airey, K. (2012) · PubMed Central · Cited by 42
QTc Prolongation Associated with Combination Therapy of Levofloxacin, Imipramine, and Fluoxetine
Nykamp, D. L., Blackmon, C. L., Schmidt, P. E., & Roberson, A. G. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e513 · Cited by 39
Cardiovascular effects of paroxetine
Kuhs, H., & Rudolf, G. A. E. (1990) · Psychopharmacology · doi:10.1007/bf02244107 · Cited by 37
Torsade de pointes induced by citalopram and amiodarone
Fayssoil, A., Issi, J., Guerbaa, M., Raynaud, J.-C., & Heroguelle, V. (2011) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2010.12.002 · Cited by 35
Effect of paroxetine on the electrocardiogram
Edwards, J. G., Goldie, A., & Papayanni-Papasthatis, S. (1989) · Psychopharmacology · doi:10.1007/bf00443420 · Cited by 33
Evaluation of the effect of paliperidone extended release and quetiapine on corrected QT intervals
Hough, D. W., Natarajan, J., Vandebosch, A., Rossenu, S., Kramer, M. L., & Eerdekens, M. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283400d58 · Cited by 33
Robinson, J., & Doogan, D. P. (1982) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1982.tb02040.x · Cited by 31
Citalopram-induced long QT syndrome and torsade de pointes: Role for concomitant therapy and disease
GREGORIO, C. D., Morabito, G., Cerrito, M., et al. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.05.060 · Cited by 30
Unterecker, S., Warrings, B., Deckert, J., & Pfuhlmann, B. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1286346 · Cited by 28
Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature
Abramson, D. W., Quinn, D. K., & Stern, T. A. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0609 · Cited by 27
Citrome, L. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10075su1.04 · Cited by 27
Fossa, A. A., Gorczyca, W. P., Wisialowski, T. A., Yasgar, A., Wang, E., Crimin, K. S., Volberg, W. A., & Zhou, J. (2006) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2006.03.007 · Cited by 27
Antidepressant drugs and heart electrical field.
Slavíček, J., Paclt, I., Hamplová, J., Kittnar, O., Trefný, Z., & Horacek, B. (1998) · PubMed · Cited by 25
Observation of QTc Prolongation in an Adolescent Girl During Fluvoxamine Pharmacotherapy
Brzozowska, A., & Werner, B. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0136 · Cited by 11
Medikamenten-assoziiertes Long-QT-Syndrom
Bruggisser, Bravo, R., & Bodmer (2009) · Praxis · doi:10.1024/1661-8157.98.24.1409 · Cited by 10
Research works printed but not linked: 19
- Chan, 2007, Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram, QJM, 100, 609, 10.1093/qjmed/hcm072 · DOI
- Brendel, 2000, Massive sertraline overdose, Ann Emerg Med, 36, 524, 10.1016/S0196-0644(00)66384-9 · doi:10.1016/s0196-0644(00)66384-9
- Yuksel, 2005, Escitalopram intoxication, Eur Psychiatry, 20, 82, 10.1016/j.eurpsy.2004.06.034 · doi:10.1016/j.eurpsy.2004.06.034
- Waring, 2010, Evaluation of a QT nomogram for risk assessment after antidepressant overdose, Br J Clin Pharmacol, 70, 881, 10.1111/j.1365-2125.2010.03728.x · doi:10.1111/j.1365-2125.2010.03728.x
- Engebretsen, 2003, Cardiotoxicity and late onset seizures with citalopram overdose, J Emerg Med, 25, 163, 10.1016/S0736-4679(03)00164-1 · doi:10.1016/s0736-4679(03)00164-1
- Blaschke D, Parwani AS, Huemer M, Rolf S, Boldt LH, Dietz R, et al: Torsades de pointes during combined treatment with risperidone and citalopram pharmacopsychiatry 2007; 40(6): 294–295 · doi:10.1055/s-2007-992147
- Venkatraman, 2008, Life-threatening overdose with lamotrigine, citalopram and chlorpheniramine, J Postgrad Med, 54, 316, 10.4103/0022-3859.43516 · doi:10.4103/0022-3859.43516
- Liotier, 2011, Drug monitoring of a case of citalopram overdose, Drug Chem Toxicol, 34, 420, 10.3109/01480545.2011.566571 · doi:10.3109/01480545.2011.566571
- Fisch, 1992, Electrocardiographic findings in sertraline depression trials, Drug Investigation, 4, 305, 10.1007/BF03259409 · doi:10.1007/bf03259409
- Baumann, 1995, The pharmacokinetics of citalopram, Rev Contemp Pharmacother, 6, 287
- Personne, 1997, Citalopram toxicity, Lancet, 350, 518, 10.1016/S0140-6736(05)63109-1 · doi:10.1016/s0140-6736(05)63109-1
- Glassman, 1984, Cardiovascular effects of tricyclic antidepressants, Annu Rev Med, 35, 503, 10.1146/annurev.me.35.020184.002443 · doi:10.1146/annurev.me.35.020184.002443
- Thomas, 2003, The antipsychotic drug chlorpromazine inhibits hERG potassium channels, Br J Pharmacol, 139, 567, 10.1038/sj.bjp.0705283 · doi:10.1038/sj.bjp.0705283
- 2007, Information for healthcare professionals: haloperidol, FDA Alert, 9
- Miceli, 2010, Effects of oral ziprasidone and oral haloperidol on QTc interval in patients with schizophrenia or schizoaffective disorder, Pharmacotherapy, 30, 127, 10.1592/phco.30.2.127 · doi:10.1592/phco.30.2.127
- Klein-Schwartz, 2007, Prospective observational multi-poison center study of ziprasidone exposures, Clin Toxicol, 45, 782, 10.1080/15563650701639006 · doi:10.1080/15563650701639006
- Manini, 2007, Delayed torsade de pointes (TdP) associated with ziprasidone overdose [abstract], Clin Toxicol (Phila), 45, 366
- Muzyk, 2011, A retrospective study exploring the effects of intramuscular aripiprazole on QTc change in agitated medically ill patients, J. Clin Psychopharmacol, 31, 532, 10.1097/JCP.0b013e318221e63b · doi:10.1097/jcp.0b013e318221e63b
- Hsu, 2007, Electrocardiographic abnormalities as predictors for over-range lithium levels, Cardiology, 103, 101, 10.1159/000082471 · doi:10.1159/000082471
Cited by
Mental health in elite athletes: International Olympic Committee consensus statement (2019)
Reardon, C. L., Hainline, B., Aron, C. M., Baron, D., Baum, A. L., Bindra, A., Budgett, R., Campriani, N., Castaldelli-Maia, J. M., Currie, A., et al. (2019) · British Journal of Sports Medicine · doi:10.1136/bjsports-2019-100715 · Cited by 1,277
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
Correll, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015) · World Psychiatry · doi:10.1002/wps.20204 · Cited by 820
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Quittner, A. L., Abbott, J., Georgiopoulos, A. M., Goldbeck, L., Smith, B., Hempstead, S. E., Marshall, B., Sabadosa, K. A., & Elborn, S. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207488 · Cited by 465
“37”
Metadata
- Authors
- Beach, S. R., Celano, C. M., Noseworthy, P. A., Januzzi, J. L., & Huffman, J. C.
- Venue
- Psychosomatics
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 54
- Issue
- 1
- Pages
- 1-13
- ISSN
- 0033-3182 (ISSN-L)
- OpenAlex
- W2010038516
- Cited by
- 345
- References
- 85
- FWCI
- 20.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.